Haleon US Inc.

Form 483

Issued to: Novartis Consumer Health

Lincoln, Nebraska, United StatesFEI 1911445Issued July 10, 2015

View Form 483 PDF

Source: FDA, document on file. FDA released the Form 483 itself. The document linked above is our copy of FDA's file, stored by us so the link cannot break, and FDA's own copy is linked beside it. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 1911445.

Observations9

Issue DateJuly 10, 2015

StatusNo Warning Letter

Establishment TypeDrug Manufacturer

Related Inspections10

Establishment Details

Firm: Haleon US Inc.
Issued To: Novartis Consumer Health
Location: Lincoln, Nebraska, United States
FEI Number: 1911445
Establishment Type: Drug Manufacturer
Product Type: Drugs
Issue Date: July 10, 2015
Country: United States

Inspection History, 2012 to 2024

NAI7

VAI1

OAI2

NAI means No Action Indicated. VAI means Voluntary Action Indicated. OAI means Official Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Haleon US Inc. FDA Form 483, Lincoln, Nebraska, July 10, 2015